SJ

Satishkumar Jayntilal Patel

Active Director Director DIN 11092759
DIN 11092759 First appointment May 2025 Primary industry Machinery and Equipment
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Satishkumar Jayntilal Patel

Data last updated:

Satishkumar Jayntilal Patel is a Director at Kts Pharmatech Private Limited (since 2025). The company operates in Machinery and Equipment.

DIN 11092759
Primary Designation Director
Industry Machinery and Equipment
First Appointment 06 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kts Pharmatech Private Limited U21009GJ2025PTC162558
Director06 May 20252025Active

Board colleagues of Satishkumar Jayntilal Patel

Directorship timeline

Open interactive timeline →
Kts Pharmatech Private Limited
Premium access

Shareholding and investment profile for Satishkumar Jayntilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satishkumar Jayntilal Patel

Satishkumar Jayntilal Patel currently holds 1 directorship: Kts Pharmatech Private Limited (Director, since 06 May 2025).

Satishkumar Jayntilal Patel was first appointed on 06 May 2025 as Director at Kts Pharmatech Private Limited.

The current boards of Satishkumar Jayntilal Patel's companies include Chintan Chandubhai Trentiya (Kts Pharmatech Private Limited), Jimitkumar Vasudevbhai Patel (Kts Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available